Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Beers

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Brain : a Journal of Neurology|May 21, 2011
Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosisDavid R Beers, Jenny S Henkel, Weihua Zhao, et al.
Brain, Behavior, & Immunity - Health|September 30, 2021
Serum programmed cell death proteins in amyotrophic lateral sclerosisDavid R Beers, Weihua Zhao, Jason R Thonhoff, et al.
Frontiers in Neurology|June 25, 2024
A phase 1 proof-of-concept study evaluating safety, tolerability, and biological marker responses with combination therapy of CTLA4-Ig and interleukin-2 in amyotrophic lateral sclerosisJason R Thonhoff, David R Beers, Weihua Zhao, et al.
Annals of Clinical and Translational Neurology|April 7, 2026
Longitudinal Assessment of Biomarkers in ALS: Discriminative Biomarkers for Disease Progression and SurvivalDavid R Beers, Yueh-Yun Lin, Jason R Thonhoff, et al.
Brain Communications|September 21, 2020
Restoring regulatory T-cell dysfunction in Alzheimer's disease through <i>ex vivo</i> expansionAlireza Faridar, Aaron D Thome, Weihua Zhao, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 31, 2018
Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human studyJason R Thonhoff, David R Beers, Weihua Zhao, et al.
Frontiers in Immunology|August 7, 2025
Peripheral monocyte transcriptional signatures of inflammation and oxidative stress in Parkinson's diseaseAaron D Thome, Jinghong Wang, Farah Atassi, et al.
Scientific Reports|September 18, 2020
Elevated acute phase proteins reflect peripheral inflammation and disease severity in patients with amyotrophic lateral sclerosisDavid R Beers, Weihua Zhao, Daniel W Neal, et al.
Molecular Neurodegeneration|November 15, 2018
Functional alterations of myeloid cells during the course of Alzheimer's diseaseAaron D Thome, Alireza Faridar, David R Beers, et al.
Plos One|November 11, 2011
Excess circulating alternatively activated myeloid (M2) cells accelerate ALS progression while inhibiting experimental autoimmune encephalomyelitisIlan Vaknin, Gilad Kunis, Omer Miller, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Brain : a Journal of Neurology|May 21, 2011
Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosisDavid R Beers, Jenny S Henkel, Weihua Zhao, et al.
Brain, Behavior, & Immunity - Health|September 30, 2021
Serum programmed cell death proteins in amyotrophic lateral sclerosisDavid R Beers, Weihua Zhao, Jason R Thonhoff, et al.
Frontiers in Neurology|June 25, 2024
A phase 1 proof-of-concept study evaluating safety, tolerability, and biological marker responses with combination therapy of CTLA4-Ig and interleukin-2 in amyotrophic lateral sclerosisJason R Thonhoff, David R Beers, Weihua Zhao, et al.
Annals of Clinical and Translational Neurology|April 7, 2026
Longitudinal Assessment of Biomarkers in ALS: Discriminative Biomarkers for Disease Progression and SurvivalDavid R Beers, Yueh-Yun Lin, Jason R Thonhoff, et al.
Brain Communications|September 21, 2020
Restoring regulatory T-cell dysfunction in Alzheimer's disease through <i>ex vivo</i> expansionAlireza Faridar, Aaron D Thome, Weihua Zhao, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 31, 2018
Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human studyJason R Thonhoff, David R Beers, Weihua Zhao, et al.
Frontiers in Immunology|August 7, 2025
Peripheral monocyte transcriptional signatures of inflammation and oxidative stress in Parkinson's diseaseAaron D Thome, Jinghong Wang, Farah Atassi, et al.
Scientific Reports|September 18, 2020
Elevated acute phase proteins reflect peripheral inflammation and disease severity in patients with amyotrophic lateral sclerosisDavid R Beers, Weihua Zhao, Daniel W Neal, et al.
Molecular Neurodegeneration|November 15, 2018
Functional alterations of myeloid cells during the course of Alzheimer's diseaseAaron D Thome, Alireza Faridar, David R Beers, et al.
Plos One|November 11, 2011
Excess circulating alternatively activated myeloid (M2) cells accelerate ALS progression while inhibiting experimental autoimmune encephalomyelitisIlan Vaknin, Gilad Kunis, Omer Miller, et al.
Pageof 5